Scenarios that move ADPT

Adaptive Biotechnologies Corporation - Common Stock

Scenarios that move ADPT: 1 analysis, 1 positive, 0 negative.

  1. · Genmab and AbbVie report positive epcoritamab lymphoma trial results — ▲ · impact +22 · confidence low · horizon quarters

All scenarios · Run a scenario · Pricing